Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$4,098,059
+$156,953 QoQ
Shares Held
16,136
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,758
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CIDEL ASSET MANAGEMENT INC holds $84,525,882 across 11 Drug Manufacturers - General names. JNJ ranks #3 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
234,663 | $44,496,798 | |
| 2 | LLY |
ELI LILLY & Co
|
19,854 | $23,813,485 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
16,136 | $4,098,059 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,925 | $2,431,862 | |
| 5 | PFE |
Pfizer Inc
|
97,941 | $2,358,419 | |
| 6 | ABBV |
AbbVie Inc.
|
9,259 | $2,329,934 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,042 | $1,903,880 | |
| 8 | AMGN |
Amgen Inc
|
3,794 | $1,373,883 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,098,059 | 16,136 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $3,941,106 | 16,123 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,017,951 | 14,583 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,877,347 | 15,518 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,397,564 | 15,696 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,665,048 | 16,070 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,362,801 | 16,338 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,576,429 | 15,898 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,401,262 | 16,429 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,496,080 | 15,779 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,656,586 | 16,949 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $971,724 | 6,239 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $27,923,555 | 168,702 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,238,435 | 156,377 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $27,543,797 | 155,923 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $25,283,227 | 154,770 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $32,162,681 | 181,188 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $31,469,313 | 177,562 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $30,958,880 | 180,972 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $31,940,178 | 197,772 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $32,607,811 | 197,935 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $30,155,266 | 183,482 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $17,531,187 | 111,394 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $26,088,093 | 175,229 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $24,767,896 | 176,121 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $27,405,383 | 208,994 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||